IRADIMED CORP 8-K

What Happened
Iradimed Corporation (IRMD) filed an 8-K on June 24, 2026 reporting the results of its Annual Meeting of Stockholders held June 23, 2026. Stockholders elected five directors (Roger Susi, Monty Allen, Joe Kiani, Hilda Scharen-Guivel and James Hawkins) to serve until the next annual meeting. Shareholders also ratified RSM US LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, and approved an advisory (non-binding) resolution on executive compensation.

Key Details

• Director election vote totals:
  • Roger Susi — For: 8,638,178; Withheld: 1,972,758; Broker Non-Votes: 759,594
  • Monty Allen — For: 9,266,549; Withheld: 1,344,387; Broker Non-Votes: 759,594
  • Joe Kiani — For: 10,492,206; Withheld: 118,730; Broker Non-Votes: 759,594
  • Hilda Scharen-Guivel — For: 10,409,481; Withheld: 201,455; Broker Non-Votes: 759,594
  • James Hawkins — For: 8,244,802; Withheld: 2,366,134; Broker Non-Votes: 759,594
• Auditor ratification: RSM US LLP — For: 11,355,891; Against: 8,716; Abstentions: 5,923.
• Advisory “say-on-pay” vote on named executive officer compensation — For: 10,487,387; Against: 106,030; Abstentions: 17,519; Broker Non-Votes: 759,594.
• Form 8-K signed by John Glenn, Chief Financial Officer, filed June 24, 2026.

Why It Matters
These results confirm the company’s board composition and auditor for fiscal 2026, and reflect clear shareholder approval of executive compensation on an advisory basis. Investors should note the vote totals and the presence of broker non-votes (759,594), and that two directors (notably James Hawkins and Roger Susi) received higher levels of withheld votes than others—information useful when assessing shareholder sentiment and governance stability. No changes to executive officers or financial results were reported in this filing.